| Bioactivity | Bortezomib-pinanediol is a proteasome inhibitor and a prodrug of Bortezomib (HY-10227). Bortezomib-pinanediol inhibits cell growth and can be used for study of multiple myeloma[1]. |
| CAS | 205393-22-2 |
| Formula | C29H39BN4O4 |
| Molar Mass | 518.46 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Gu Z, et al. Hyaluronic acid shell and disulfide-crosslinked core micelles for in vivo targeted delivery of bortezomib for the treatment of multiple myeloma. Acta Biomater. 2018;80:288-295. |
Bortezomib-pinanediol
CAS: 205393-22-2 F: C29H39BN4O4 W: 518.46
Bortezomib-pinanediol is a proteasome inhibitor and a prodrug of Bortezomib (HY-10227). Bortezomib-pinanediol inhibits c
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.